These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30371161)

  • 21. Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial.
    Holt TA; Fitzmaurice DA; Marshall T; Fay M; Qureshi N; Dalton AR; Hobbs FD; Lasserson DS; Kearley K; Hislop J; Jin J
    Trials; 2013 Nov; 14():385. PubMed ID: 24220602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry.
    Fosbol EL; Holmes DN; Piccini JP; Thomas L; Reiffel JA; Mills RM; Kowey P; Mahaffey K; Gersh BJ; Peterson ED;
    J Am Heart Assoc; 2013 Jul; 2(4):e000110. PubMed ID: 23868192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of a personalized and distributed patient guidance system.
    Peleg M; Shahar Y; Quaglini S; Broens T; Budasu R; Fung N; Fux A; García-Sáez G; Goldstein A; González-Ferrer A; Hermens H; Hernando ME; Jones V; Klebanov G; Klimov D; Knoppel D; Larburu N; Marcos C; Martínez-Sarriegui I; Napolitano C; Pallàs À; Palomares A; Parimbelli E; Pons B; Rigla M; Sacchi L; Shalom E; Soffer P; van Schooten B
    Int J Med Inform; 2017 May; 101():108-130. PubMed ID: 28347441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Boriani G; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Maggioni AP; Tavazzi L
    Europace; 2015 Feb; 17(2):194-206. PubMed ID: 25149078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical decision support for stroke prevention in atrial fibrillation (CDS-AF): Rationale and design of a cluster randomized trial in the primary care setting.
    Karlsson LO; Nilsson S; Charitakis E; Bång M; Johansson G; Nilsson L; Janzon M
    Am Heart J; 2017 May; 187():45-52. PubMed ID: 28454807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of Long-Term Anticoagulation After Catheter Ablation of Atrial Fibrillation.
    Arias R; Leef G; Daimee U; Sivasambu B; Akhtar T; Marine JE; Berger R; Calkins H; Spragg D
    Am J Cardiol; 2020 Aug; 128():12-15. PubMed ID: 32650904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An interrupted time series study of electronic health record clinical decision support for providers caring for patients with atrial fibrillation at increased stroke risk.
    Osterland AJ; Yasuda M; Widmer RJ; Colavecchia AC; Gums T; Emir B; Nolen K; MacLean E; Godley PJ
    Am J Health Syst Pharm; 2023 Dec; 80(24):1830-1839. PubMed ID: 37696764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial.
    Ashburner JM; Atlas SJ; Khurshid S; Weng LC; Hulme OL; Chang Y; Singer DE; Ellinor PT; Lubitz SA
    J Gen Intern Med; 2018 Dec; 33(12):2070-2077. PubMed ID: 30076573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electronic alerts for ambulatory patients with atrial fibrillation not prescribed anticoagulation: A randomized, controlled trial (AF-ALERT2).
    Piazza G; Hurwitz S; Campia U; Bikdeli B; Lou J; Khairani CD; Bejjani A; Snyder JE; Pfeferman M; Barns B; Rizzo S; Glezer A; Goldhaber SZ
    Thromb Res; 2023 Jul; 227():1-7. PubMed ID: 37182298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?
    Eckman MH; Wise R; Knochelmann C; Mardis R; Leonard AC; Wright S; Gummadi A; Dixon E; Becker RC; Schauer DP; Flaherty ML; Costea A; Kleindorfer D; Ireton R; Baker P; Harnett BM; Adejare A; Sucharew H; Arduser L; Kues J
    J Cardiol; 2024 May; 83(5):285-290. PubMed ID: 37579873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.
    O'Neal WT; Claxton JS; Sandesara PB; MacLehose RF; Chen LY; Bengtson LGS; Chamberlain AM; Norby FL; Lutsey PL; Alonso A
    J Am Coll Cardiol; 2018 Oct; 72(16):1913-1922. PubMed ID: 30309468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting.
    McCormick D; Gurwitz JH; Goldberg RJ; Becker R; Tate JP; Elwell A; Radford MJ
    Arch Intern Med; 2001 Nov; 161(20):2458-63. PubMed ID: 11700158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy : Piazza: outcomes of high-bleeding risk AF patients.
    Piazza G; Hurwitz S; Carroll B; Goldhaber SZ
    J Thromb Thrombolysis; 2021 Jul; 52(1):281-290. PubMed ID: 33000390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands--The EXAMINE-AF study. A questionnaire survey.
    Dinh T; Nieuwlaat R; Tieleman RG; Büller HR; van Charante NA; Prins MH; Crijns HJ
    Int J Clin Pract; 2007 Jan; 61(1):24-31. PubMed ID: 17229177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS
    Chapman SA; St Hill CA; Little MM; Swanoski MT; Scheiner SR; Ware KB; Lutfiyya MN
    BMC Health Serv Res; 2017 Feb; 17(1):127. PubMed ID: 28187730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
    Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
    J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stepped-wedge randomised trial to evaluate population health intervention designed to increase appropriate anticoagulation in patients with atrial fibrillation.
    Wang SV; Rogers JR; Jin Y; DeiCicchi D; Dejene S; Connors JM; Bates DW; Glynn RJ; Fischer MA
    BMJ Qual Saf; 2019 Oct; 28(10):835-842. PubMed ID: 31243156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation: estimated excess rate of stroke due to lacking adherence to guidelines.
    Zehnder BS; Schaer BA; Jeker U; Cron TA; Osswald S
    Swiss Med Wkly; 2006 Dec; 136(47-48):757-60. PubMed ID: 17225195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.